Login
$ZYME
$26.45 +$0.21 (0.8%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Kenneth Galbraith Also a director
Chief Executive Officer, President and Chair of Board of Directors
64 Not stated Not stated $6,613,180
Kristin Stafford
Executive Vice President and Chief Financial Officer
44 Not stated 2026 Not reported
Paul A. Moore
Chief Scientific Officer
60 Not stated 2022 $2,348,190
Sabeen Mekan
Senior Vice President and Chief Medical Officer
47 Since 2026
this year
2025 Not reported
Scott Platshon
Executive Vice President and Chief Business Officer
35 Since 2026
this year
Not stated Not reported
Paul Schneider
Executive Vice President and General Counsel
56 Not stated Not stated Not reported
Adam Schayowitz
Executive Vice President and Head of R&D
46 Since 2026
this year
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
2.4 years
from year joined
CEO also chairs the board
Yes
Kenneth Galbraith
Director Age On board Independent Committees Other public boards 2025 pay Source
Kenneth Galbraith
64 2022
4 years
Not independent None stated None stated Paid as CEO
Brian N. Cherry
52 2026
this year
Independent
Audit
Atara Biotherapeutics Not stated
Gregory A. Ciongoli
51 2025
1 year
Independent
Nominating and Corporate Governance · Chair
REGENXBIO Inc. Not stated
Oleg Nodelman
49 2025
1 year
Independent
Compensation
Galapagos NV Not stated
Carlos Campoy
62 2023
3 years
Independent
Audit · Chair
None stated $65,000
Alessandra Cesano
66 2024
2 years
Independent
Nominating and Corporate Governance
Puma Biotechnology, Inc. $51,875
Kelvin Neu
52 2020
6 years
Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Oct 26, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support